Distributional cost-effectiveness analysis
{Distributional cost-effectiveness analysis (DCEA) is an extension of standard cost-effectiveness analysis that incorporates concern for both the average levels of outcomes as well as the distribution of outcomes. It is particularly useful when evaluating interventions to tackle health inequality.[1][2]
DCEA includes Extended Cost Effectiveness Analysis, which in addition to standard CEA assesses the costs and effectiveness for different socioeconomic groups.[3]
References
- ^ Asaria, M; Griffin, S; Cookson, R; Whyte, S; Tappenden, P (June 2015). "Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme" (PDF). Health Economics. 24 (6): 742–54. doi:10.1002/hec.3058. PMID 24798212.
- ^ Asaria, M; Griffin, S; Cookson, R (January 2016). "Distributional Cost-Effectiveness Analysis: A Tutorial". Medical Decision Making. 36 (1): 8–19. doi:10.1177/0272989x15583266. PMC 4853814. PMID 25908564.
- ^ Verguet, Stéphane; Kim, Jane J.; Jamison, Dean T. (2016). "Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial". Pharmacoeconomics. 34 (9): 913–923. doi:10.1007/s40273-016-0414-z. ISSN 1170-7690. PMC 4980400. PMID 27374172.
 | This accounting-related article is a stub. You can help Wikipedia by expanding it. |
 | This health-related article is a stub. You can help Wikipedia by expanding it. |